Learn / DNTH
NASDAQ: DNTH
Dianthus Therapeutics, Inc. /DE/ (DNTH) stock, explained like you're 5
Dianthus Therapeutics, Inc. /DE/ trades on the Nasdaq under the ticker DNTH. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 4.6 billion dollars.
- Ticker
- DNTH
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 4.6 billion dollars
Is Dianthus Therapeutics, Inc. /DE/ a small, medium or large cap company?
No. Dianthus Therapeutics, Inc. /DE/ is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 4.6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Dianthus Therapeutics, Inc. /DE/ makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves DNTH stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- 451,597 Dianthus Therapeutics, Inc. $DNTH Shares Purchased by Assenagon Asset Management S.A. (MarketBeat)
- DNTH Mar 2027 40.000 call (DNTH270319C00040000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- (DNTH) Movement as an Input in Quant Signal Sets (Stock Traders Daily)
- DNTH Feb 2027 75.000 put (DNTH270219P00075000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Dianthus Therapeutics (NASDAQ:DNTH) Earns "Buy" Rating from HC Wainwright (MarketBeat)
Follow DNTH in your daily brief
Each trading day at 5 PM ET we post what happened to Dianthus Therapeutics, Inc. /DE/ and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow DNTH
Questions about Dianthus Therapeutics, Inc. /DE/ stock
What does Dianthus Therapeutics, Inc. /DE/ do?
Dianthus Therapeutics, Inc. /DE/ trades on the Nasdaq under the ticker DNTH. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 4.6 billion dollars.
What is the ticker symbol for Dianthus Therapeutics, Inc. /DE/?
Dianthus Therapeutics, Inc. /DE/ trades under the ticker DNTH on the Nasdaq.
What is Dianthus Therapeutics, Inc. /DE/'s market cap?
Dianthus Therapeutics, Inc. /DE/ is a mid cap stock with a market cap of about 4.6 billion dollars.
How does Dianthus Therapeutics, Inc. /DE/ make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves DNTH stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow DNTH stock every day?
Add DNTH to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.